Sleep Duration And Treatment Compliance: A Population-based Cross-sectional Study Of Hypertensive Patients In Bangladesh | 50275
Journal of Clinical & Experimental Cardiology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Treatment with appropriate medication is a key factor to control hypertension and reduce the associated risk of complications.
However, compliance with treatment is often sub-optimal, especially in developing countries. Our aim in this cross-sectional study
is to investigate an association between sleep duration and treatment compliance among skilled professionals who are experiencing
hypertension. A questionnaire was given to all skilled professionals. Who are found hypertensive in an organization of Bangladesh. To
assess treatment compliance, questions on self-reported compliance test were used. We collected information on self-reported short
sleep duration (6 h or less) along with socio-demographic factors and clinical conditions of the subjects. Sleep duration is associated
with compliance with treatment among hypertensive skilled professionals. We found overall associations of sleep duration [odds
ratio (OR) 3.77, confidence interval 1.44-10.83] with treatment compliance among hypertensive patients. In addition, body mass
index (OR 1.19), marital status (OR 0.16) and duration of having hypertension are found significant factors for non-compliance with
treatment. There is an association between sleep duration and treatment compliance among the hypertensive patients. However, the
study is conducted with a small group of skilled professionals from an organization and it is important to include multi-centers to
validate the conclusion.